HOW RELIABLE IS A NEGATIVE MRI/TRUS FUSION BIOPSY? THE NEGATIVE PREDICTIVE VALUE OF TARGETED BIOPSY FOR PROSTATE CANCER

被引：0
|
作者：
Sussman, Rachael
Fascelli, Michele
Frye, Thomas
George, Arvin
Abboud, Steven
Chelluri, Raju
Ho, Richard
Brown, Anna
Sankineni, Sandeep
Merino, Maria
Turkbey, Ismail
Choyke, Peter
Wood, Bradford
Pinto, Peter
机构：
来源：
JOURNAL OF UROLOGY | 2015年 / 193卷 / 04期
关键词：
D O I：
10.1016/j.juro.2015.02.1678
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP48-04
引用
收藏
页码：E595 / E595
页数：1
相关论文
共 50 条
  • [21] ANALYSIS OF CLINICAL AND ONCOLOGICAL FOLLOW-UP AFTER NEGATIVE MRI-TRUS FUSION BIOPSY OF THE PROSTATE
    von Landenberg, Nicolas
    Noldus, Joachim
    Hanske, Julian
    Berg, Sebastian
    Brock, Marko
    JOURNAL OF UROLOGY, 2019, 201 (04): : E422 - E423
  • [22] Predictive value of prostatic adenocarcinoma after a negative prostate biopsy
    Park, Paul C.
    Mai, Kien T.
    Delatour, Nicolas L. D. Roustan
    Morash, Christopher
    Cagiannos, Ilias
    BJU INTERNATIONAL, 2006, 98 (05) : 986 - 988
  • [23] The role of MRI/TRUS fusion biopsy in the diagnosis of clinically significant prostate cancer
    Benelli, Andrea
    Vaccaro, Chiara
    Guzzo, Sonia
    Nedbal, Carlotta
    Varca, Virginia
    Gregori, Andrea
    THERAPEUTIC ADVANCES IN UROLOGY, 2020, 12
  • [24] CAN PSMA-TARGETED PROSTATE BIOPSY DETECT CANCER WHEN MRI-GUIDED BIOPSY IS NEGATIVE?
    Brisbane, Wayne G.
    Topoozian, Mark T.
    Calais, Jeremie
    Delfin, Merdie K.
    Kwan, Lorna
    Gonzalez, Samantha R.
    Marks, Leonard S.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1057 - E1058
  • [25] THE ROLE OF THE OPERATOR IN THE CANCER DETECTION WITH MRI/TRUS FUSION TRANSRECTAL PROSTATE BIOPSY
    Porpiglia, Francesco
    Cossu, Marco
    De Luca, Stefano
    Manfredi, Matteo
    Mele, Fabrizio
    Bertolo, Riccardo
    Amparore, Daniele
    Checcucci, Enrico
    Garrou, Diletta
    De Pascale, Agostino
    Russo, Filippo
    Fiori, Cristian
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1028 - E1028
  • [26] PROSTATE CANCER DETECTION AFTER NEGATIVE BIOPSY: MRI, BIOMARKER OR SYSTEMATIC BIOPSY
    Cheung, Douglas
    Magee, Diana
    Hird, Amanda
    Perlis, Nathan
    Finelli, Antonio
    Kulkarni, Girish
    JOURNAL OF UROLOGY, 2020, 203 : E998 - E998
  • [27] Prostate MRI and transperineal TRUS/MRI fusion biopsy for prostate cancer detection: clinical practice updates
    Martorana, Eugenio
    Pirola, Giacomo Maria
    Aisa, Maria Cristina
    Scialpi, Pietro
    Di Blasi, Aldo
    Saredi, Giovanni
    D'Andrea, Alfredo
    Signore, Stefano
    Grisanti, Riccardo
    Scialpi, Michele
    TURKISH JOURNAL OF UROLOGY, 2019, 45 (04): : 237 - 244
  • [28] Techniques and Outcomes of MRI-TRUS Fusion Prostate Biopsy
    Kaneko, Masatomo
    Sugano, Dordaneh
    Lebastchi, Amir H.
    Duddalwar, Vinay
    Nabhani, Jamal
    Haiman, Christopher
    Gill, Inderbir S.
    Cacciamani, Giovanni E.
    Abreu, Andre Luis
    CURRENT UROLOGY REPORTS, 2021, 22 (04)
  • [29] Techniques and Outcomes of MRI-TRUS Fusion Prostate Biopsy
    Masatomo Kaneko
    Dordaneh Sugano
    Amir H. Lebastchi
    Vinay Duddalwar
    Jamal Nabhani
    Christopher Haiman
    Inderbir S. Gill
    Giovanni E. Cacciamani
    Andre Luis Abreu
    Current Urology Reports, 2021, 22
  • [30] Negative influence of changing biopsy practice patterns on the predictive value of prostate-specific antigen for cancer detection on prostate biopsy
    Schwartz, Michael J.
    Hwang, David H.
    Hung, Andrew J.
    Han, Juliet
    McClain, Justin W.
    Shemtov, M. Mendel
    Te, Alexis E.
    Sosa, R. Ernest
    Vaughan, E. Darracott, Jr.
    Scherr, Douglas S.
    CANCER, 2008, 112 (08) : 1718 - 1725
12345